Delivery Order SPE2DB24D2010-SPE2DB25FABEP
- Not listed
- The Defense Logistics Agency awarded a $3,943.88 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Copaxone 20 mg/ml syringes, with an ultimate completion date of August 26, 2025. This non-set-aside contract represents a direct procurement of pharmaceutical supplies to support federal medical needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for the federal government, with particular emphasis on...
- The Defense Logistics Agency awarded a delivery order valued at $2,989.35 to AmerisourceBergen Drug Corp for Copaxone 40 mg/ml syringes, with completion scheduled for July 22, 2025. This non-set-aside, competitively awarded contract reflects a firm fixed price arrangement typical of pharmaceutical procurement through the federal medical supply chain. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for...
- The Defense Logistics Agency awarded a $1,638.00 delivery order to AmerisourceBergen Drug Corp for Copaxone 40 mg/ml syringes, with a completion date of September 10, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 through December 2026. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen...
- The Defense Logistics Agency awarded a delivery order valued at $10,510.43 to AmerisourceBergen Drug Corp for the supply of Copaxone 20 mg/ml syringes. The contract, issued on August 18, 2025, with an ultimate completion date of August 19, 2025, carries firm fixed pricing with no set-aside designation, indicating competitive award status. Performance will occur at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. This delivery order represents a child contract executed...
- The Defense Logistics Agency awarded a $2,718.36 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Copaxone 40 mg/ml syringes, with completion scheduled for September 15, 2025. This non-set-aside contract represents a competitively awarded delivery order issued under AmerisourceBergen's broader pharmaceutical supply vehicle with DLA. The product will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for Copaxone 40 mg/mL syringes under a firm fixed-price contract with a ceiling value of $1,128.54. This non-set-aside award was issued on September 2, 2025, with an ultimate completion date of September 3, 2025, and represents a direct delivery order fulfillment. The place of performance is located in Conshohocken, Pennsylvania, the company's corporate headquarters. AmerisourceBergen Drug Corp, a major...
- The U.S. Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of COPAXONE 40 MG/ML SYRINGE. The $1,055.54 delivery order, which does not have a set-aside designation, has a completion date of February 7, 2024. AmerisourceBergen Drug Corp is also the prime contractor on a larger indefinite delivery contract (IDC) awarded by DLA with a...
- The Defense Logistics Agency has awarded a firm fixed price delivery order contract worth $1,069.46 to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of COPAXONE 40 MG/ML syringes. The contract has a completion date of February 16, 2024. Amerisourcebergen Drug Corp is a prime contractor that provides a wide range of pharmaceutical products and medical supplies to U.S. government agencies, including the Department of Defense. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 25, 2025, for the supply of Copaxone 40 mg/ml syringes under a firm fixed-price contract valued at $7,950.72. This is a non-set-aside competitive award with an ultimate completion date of August 26, 2025, and performance will be executed at the contractor's facility in Conshohocken, Pennsylvania. Copaxone is a disease-modifying therapy used in the treatment of multiple sclerosis, and this delivery...
- This is a $2,684.80 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of COPAXONE 20 MG/ML SYRINGEML, a medication, with a period of performance through July 9, 2025. AmerisourceBergen Drug Corp is the prime contractor, and the contract has no set-aside designation, indicating open competition. The award is associated with AmerisourceBergen Drug Corp's larger...
- SPE2DB24D2010Indefinite Delivery Contract
- SPE2DB24D2010-SPE2DB25FABEPDelivery Order
The Defense Logistics Agency awarded a $5,051.58 delivery order to AmerisourceBergen Drug Corp for COPAXONE 20 mg/ml syringes, with an ultimate completion date of September 15, 2025. This is a firm fixed price, non-set-aside contract issued on September 12, 2025, with performance at the contractor's Conshohocken, Pennsylvania facility. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems through the Defense Logistics Agency's Medical Supply Chain. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. This prime vehicle enables the contractor to supply a comprehensive global range of pharmaceutical products and medical supplies supporting military healthcare programs worldwide, including specialty medications, generic drugs, vaccines, and related medical commodities across multiple therapeutic domains. The underlying IDC serves defense customers including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $5.1k | 9/12/25 |